AAN 2020: Fingolimod and Natalizumab Prevent the Accumulation of Microstructural Tissue Damage in Both Slowly Expanding and Non-slowly Expanding Lesions of RRMS
Chronic active lesions were assessed using magnetization transfer and T1-weighted sequencing.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.